
Meet the Capital Markets Fellows

Technology Enabling Decentralized Trials, Novel Endpoints, Real World Data

Master Protocols, Adaptive Designs, and Bayesian Statistics – Oh My

Opportunities for Patient Group Engagement in Clinical Trials

The Drive for More Diverse and Representative Clinical Trials

Antibiotic Resistance and Chronic Disease: Understanding the Challenges and Some Possible Solutions

The Impact of Investing in Health Equity in Biomedical Research

Virtual Program | A Conversation with Marcella Nunez-Smith on COVID-19 and Health Equity

Lunch Program | Promoting Prosperity in a World in Transition

The Case for Investing in Migrants and Refugees
